Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Bio-Techne Corp shares valued at $960,388 were sold by Nusse Roeland on Aug 25 ’25. At $56.36 per share, Nusse Roeland sold 17,040 shares. The insider’s holdings dropped to 44,559 shares worth approximately $2.36 million following the completion of this transaction.
Also, BAUMGARTNER ROBERT V sold 17,040 shares, netting a total of over 957,818 in proceeds. Following the sale of shares at $56.21 each, the insider now holds 44,863 shares.
Before that, ROELAND NUSSE had added 17,040 shares to its account. In a trade valued at $960,388, the Director bought Bio-Techne Corp shares for $56.36 each.
As published in a research note from RBC Capital Mkts on September 03, 2025, Bio-Techne Corp [TECH] has been rated up from a Sector perform to an Outperform and the price target has been revised to $73. Analysts at Citigroup upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late August. Earlier on July 09, 2025, TD Cowen initiated its rating. Their recommendation was “a Buy” for TECH stock.
Analyzing TECH Stock Performance
On last trading session, Bio-Techne Corp [NASDAQ: TECH] plunged -0.79% to $52.92. The stock’s lowest price that day was $51.615, but it reached a high of $53.19 in the same session. During the last five days, there has been a drop of approximately -5.87%. Over the course of the year, Bio-Techne Corp shares have dropped approximately -28.48%. Shares of the company reached a 52-week high of $79.28 on 02/05/25 and a 52-week low of $46.01 on 04/21/25.
Support And Resistance Levels for Bio-Techne Corp (TECH)
According to the 24-hour chart, there is a support level at 51.96, which, if violated, would cause prices to drop to 51.00. In the upper region, resistance lies at 53.53. The next price resistance is at 54.15. RSI (Relative Strength Index) is 45.01 on the 14-day chart, showing neutral technical sentiment.
Is Bio-Techne Corp subject to short interest?
Stocks of Bio-Techne Corp saw a sharp steep in short interest on 2025-08-15 dropping by -0.76 million shares to 5.77 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 6.53 million shares. A decline of -13.13% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.47 of the overall float, the days-to-cover ratio (short ratio) decline to 2.47.
Which companies own the most shares of Bio-Techne Corp (TECH)?
In terms of Bio-Techne Corp share price expectations, FactSet research, analysts set an average price target of 74 in the next 12 months, up nearly 38.73% from the previous closing price of $53.34. Analysts anticipate Bio-Techne Corp stock to reach 75 by 2025, with the lowest price target being 73. In spite of this, 7 analysts ranked Bio-Techne Corp stock as Buy at the end of 2025. On May 30, 2025, Wells Fargo assigned a price target of “an Overweight” to the stock and initiated coverage with a $59.
